NCT06141590View on ClinicalTrials.gov

A Clinical Study to Evaluate the Safety and the Pharmacokinetics of UI068 in Healthy Adult Volunteers Under Fed Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

March 11, 2023

Primary Completion Date

August 29, 2023

Study Completion Date

August 29, 2023

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

administration of UI068

Test

DRUG

administration of UIC202205, UIC202206

Reference

Trial Locations (1)

08779

H plus Yangji Hospital, Seoul

All Listed Sponsors

lead

Korea United Pharm. Inc.

INDUSTRY